MLICM
TNGX icon

Metropolitan Life Insurance Company (MetLife)’s Tango Therapeutics TNGX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,484
Closed -$19.7K – 1934
2024
Q1 		$19.7K Hold
2,484
– – ﹤0.01% 1872
2023
Q4 		$24.6K Hold
2,484
– – ﹤0.01% 1821
2023
Q3 		$28K Hold
2,484
– – ﹤0.01% 1722
2023
Q2 		$8.25K Hold
2,484
– – ﹤0.01% 2388
2023
Q1 		$9.81K Sell
2,484
-822
-25% -$4.77K ﹤0.01% 2164
2022
Q4 		$24K Buy
+3,306
New +$23.3K ﹤0.01% 1910
2022
Q3 		– Sell
-3,324
Closed -$15.1K – 2354
2022
Q2 		$15.1K Buy
+3,324
New +$20.1K ﹤0.01% 2180

Other funds holding TNGX

TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s TNGX Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Tango Therapeutics (TNGX) in Q2 2024, closing a stake of 2,484 shares — an estimated $19.7K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in TNGX in Q2 2022 and held it in 7 quarters. The position peaked at $28K in Q3 2023. 119 funds tracked by Wall St. Rank hold TNGX as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Tango Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,484 Tango Therapeutics shares in Q2 2024, an estimated $19.7K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Tango Therapeutics in Q2 2022 and held it in 7 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Tango Therapeutics position peaked at $28K in Q3 2023.
  • 119 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.